Introduction
Methods
CT scan
Lesion segmentation
Inter- and intra-operator reliability
Lesions size
Results
Data analyses
Inter-operator | Intra-operator | ||||
---|---|---|---|---|---|
First segmentation | Second segmentation | Operator I | Operator II | ||
Mean DC (± SD) | Osteolytic | 0.54 (± 0.26) | 0.45 (± 0.31) | 0.56 (± 0.26) | 0.63 (± 0.27) |
Osteoblastic | 0.57 (± 0.28) | 0.60 (± 0.27) | 0.60 (± 0.28) | 0.78 (± 0.12) | |
Mixed | 0.51 (± 0.29) | 0.46 (± 0.34) | 0.52 (± 0.3) | 0.74 (± 0.23) | |
Mean segmentation volume (± SD) | Osteolytic | 14.48 (± 13.83) | 12.88 (± 10.79) | 14.44 (± 13.65) | 12.92 (± 11.76) |
Osteoblastic | 33.35 (± 32.42) | 37.12 (± 40.56) | 32.51 (± 36.74) | 37.95 (± 37.77) | |
Mixed | 41.2 (± 27.47) | 35 (± 28.39) | 28.72 (± 24.78) | 47.48 (± 35.82) |
Lesion size
Inter-operator | Intra-operator | ||
---|---|---|---|
Mean DC (± SD) | ˃60 cm3 | 0.74 (± 0.16) | 0.81 (± 0.07) |
˂60 cm3 | 0.49 (± 0.3) | 0.61 (± 0.28) |
Discussion
Conclusion
Patient ID | Sex (m = male; f = female) | Age (years) | Primary cancer type | Radiotherapy treatment |
---|---|---|---|---|
PT-01 | m | 55 | Prostate | 1 × 8 Gy |
PT-02 | m | 59 | Kidney | 2 × 8 Gy |
PT-03 | m | 82 | Lung | 5 × 4 Gy |
PT-04 | m | 74 | Prostate | 1 × 8 Gy |
PT-05 | m | 68 | Multiple myeloma | 1 × 8 Gy |
PT-06 | f | 61 | Lung | 1 × 8 Gy |
PT-07 | f | 50 | Breast | 1 × 8 Gy |
PT-08 | m | 73 | Prostate | 1 × 8 Gy |
PT-09 | m | 74 | Non-Hodgkin lymphoma | 10 × 3 Gy |
PT-10 | f | 66 | Breast | 1 × 8 Gy |
PT-11 | f | 60 | Lung | After surgery 5 × 4 Gy |
PT-12 | m | 70 | Prostate | 5 × 4 Gy |
PT-13 | f | 68 | Breast | 1 × 8 Gy |
PT-14 | m | 65 | Prostate | 1 × 8 Gy |
PT-15 | m | 72 | Prostate | 1 × 8 Gy |
PT-16 | m | 87 | Prostate | 1 × 8 Gy |
PT-17 | m | 75 | Prostate | 1 × 8 Gy |
PT-18 | m | 72 | Prostate | 1 × 8 Gy |
PT-19 | m | 75 | Prostate | 5 × 4 Gy |
PT-20 | m | 95 | Prostate | No RT |
PT-21 | f | 41 | Breast | 1 × 8 Gy |
PT-22 | f | 67 | Lung | 1 × 8 Gy |
PT-23 | f | 74 | Multiple myeloma | 1 × 8 Gy |
PT-24 | f | 55 | Kidney | 5 × 4 Gy |
PT-25 | m | 60 | Multiple myeloma | Not available |
PT-26 | m | 80 | Prostate | 1 × 8 Gy |
PT-27 | m | 70 | Prostate | 5 × 4 Gy |
PT-28 | m | 80 | Prostate | 1 × 8 Gy |
PT-29 | m | 82 | Prostate | 1 × 8 Gy |
PT-30 | f | 72 | Lung | 1 × 8 Gy |
PT-31 | m | 87 | Prostate | Not available |
PT-32 | f | 61 | Breast | 1 × 8 Gy |
PT-33 | f | 69 | Multiple myeloma | 5 × 4 Gy |
PT-34 | m | 53 | Lung | 1 × 8 Gy |
PT-35 | m | 66 | Prostate | 1 × 8 Gy |
PT-36 | m | 77 | Multiple myeloma | 5 × 4 Gy |
PT-37 | m | 48 | Lung | 1 × 8 Gy |
PT-38 | m | 55 | Prostate | 1 × 8 Gy |
PT-39 | f | 51 | Lung | 1 × 8 Gy |
PT-40 | f | 65 | Lung | 1 × 8 Gy |
PT-41 | f | 67 | Lung | 1 × 8 Gy |
PT-42 | m | 86 | Prostate | 1 × 8 Gy |
PT-43 | f | 68 | Breast | 1 × 8 Gy |
PT-44 | m | 57 | Lung | 1 × 8 Gy |
PT-45 | f | 78 | Lung | 5 × 4 Gy |
PT-46 | m | 82 | Prostate | 1 × 8 Gy |
PT-47 | m | 64 | Esophagus | 1 × 8 Gy |
PT-48 | f | 68 | Breast | 1 × 8 Gy |
PT-49 | f | 75 | Breast | 1 × 8 Gy |
PT-50 | m | 66 | Prostate | 1 × 8 Gy |
PT-51 | f | 69 | Breast | 1 × 8 Gy |
PT-52 | m | 57 | Multiple myeloma | 5 × 4 Gy |
PT-53 | m | 77 | Lung | 1 × 8 Gy |
PT-54 | f | 58 | Breast | 1 × 8 Gy |